Kaposi sarcoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

12Recruiting trials

Regulatory Watchboard

10 events

Sep 2026A Study of Propranolol to Treat Kaposi Sarcoma

AIDS Malignancy Consortium — PHASE2

TrialNOT YET RECRUITING

May 2026Precision Imaging to Evaluate Kaposi Sarcoma

Washington University School of Medicine — NA

TrialNOT YET RECRUITING

Aug 2025Propranolol for the Treatment of Kaposi Sarcoma in Adults

Washington University School of Medicine — PHASE2

TrialRECRUITING

Feb 2025Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial

Washington University School of Medicine

TrialRECRUITING

May 2024Natural History Study of Kaposi Sarcoma

National Cancer Institute (NCI)

TrialRECRUITING

Nov 2023Trial of Ixazomib for Kaposi Sarcoma

AIDS Malignancy Consortium — PHASE2

TrialRECRUITING

May 2023Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma

Imperial College London — PHASE1

TrialACTIVE NOT RECRUITING

Mar 2022Pomalidomide Treatment in Patients With Kaposi Sarcoma

National Cancer Institute (NCI) — PHASE2

TrialACTIVE NOT RECRUITING

Feb 2021Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis

National Cancer Institute (NCI) — NA

TrialACTIVE NOT RECRUITING

Sep 2020A Study of sEphB4-HSA in Kaposi Sarcoma

Vasgene Therapeutics, Inc — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

POMALYSTï¿½

Celgene Corporation

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

POMALYSTï¿½

(pomalidomide)Orphan drug

Celgene Corporation

Thalidomide Analog [EPC]

12.1 Mechanism of Action Pomalidomide is an analogue of thalidomide with immunomodulatory, antiangiogenic, and antineoplastic properties. Cellular act...

Approved May 2020FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

12 active trials

5Phase 2

2Phase 1

2N/A

2Unknown

1PHASE1, PHASE2

12Total recruiting

Search clinical trials for Kaposi sarcoma →

Recent News & Research

No recent news articles indexed yet for Kaposi sarcoma.
Search PubMed for Kaposi sarcoma →

Browse all Kaposi sarcoma news →

Specialist Network

Top 6 by expertise

Robert Yarchoan, M.D.

National Cancer Institute (NCI)

📍 Bethesda, Maryland

Score 3213 trials

Ramya M Ramaswami, M.D.

National Cancer Institute (NCI)

📍 Bethesda, Maryland

Score 2310 trials

Robert Maki, MD, PhD, MD, PhD

Memorial Sloan Kettering Cancer Center

📍 PHILADELPHIA, PA

Score 108 trials

Erin Reid, MD

AIDS Malignancy Consortium

Score 101 trial

Samantha L Vogt

AIDS Malignancy Consortium

Score 101 trial

Lucia Brambilla, MD

Dermatologic Unit, Ospedale Maggiore Policlinico, Milan, Italy

Score 41 trial1 pub

View all Kaposi sarcoma specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles